ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Growth Hormone
Preclinical

GHRP-6

GHRP-6

Also known as: Growth Hormone Releasing Hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

Overview

Key Facts

Primary Goal: Stimulate growth hormone release for muscle growth and recovery

GHRP-6 is a potent growth hormone secretagogue that stimulates GH release through ghrelin receptor activation. Known for strong appetite stimulation, it supports muscle growth, enhanced recovery, and improved body composition through elevated growth hormone and IGF-1 levels.

Dosing Information

Half-Life

2-3 hours

Typical Dose

100-300 mcg

Frequency

2-3x daily

Cycle Length

8-16 weeks

Administration Routes:
subcutaneous

Benefits

  • Potent growth hormone release
  • Strong appetite stimulation for those seeking weight gain
  • Enhanced muscle growth and nitrogen retention
  • Improved recovery from training
  • Cytoprotective effects on cardiac tissue shown in research

Side Effects

Intense hunger within 20 minutes of administrationmild
Elevated cortisol and prolactin at higher dosesmild
Water retention and bloatingmild
Possible blood sugar fluctuationsmild

Mechanism of Action

1

Agonizes the GHS-R1a (ghrelin) receptor to stimulate GH release from the pituitary

2

Activates hypothalamic appetite centres via ghrelin pathway signaling

3

Increases gastric motility and gastric acid secretion

4

Triggers modest cortisol and prolactin co-release through non-selective receptor activation

Contraindications

Do not use this peptide if any of the following apply:

  • Obesity or conditions where appetite stimulation is undesirable
  • Active malignancy
  • Uncontrolled diabetes

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F) or -20°C (-4°F) for long-term
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2-4 weeks

Research Summary

Preclinical

GHRP-6 was one of the first synthetic GH secretagogues developed, extensively studied since the 1980s. It has been shown to produce robust, dose-dependent GH release, though with less selectivity than newer GHRPs. Preclinical research has also identified cardioprotective properties, with studies showing reduced infarct size in animal models of myocardial ischemia.

Frequently Asked Questions

Common questions about GHRP-6

UK-Specific Information

Exclusive data points and guidance for UK residents using GHRP-6

UK Lab Testing

UK Lab Testing

Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With

Note: Peptide stacking should only be done under the guidance of a qualified healthcare professional. Individual responses may vary.

Share on TikTok

Generate a trackable link to share this peptide information on TikTok